Rankings
▼
Calendar
ICCC (ImmuCell Corporation) Stock Financials & Earnings | Market Cap Arena
ICCC
ImmuCell Corporation
Mkt Cap
$60M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$28M
Net Income (TTM)
-$1M
EPS (TTM)
-$0.11
Free Cash Flow (TTM)
$715,351
Gross Margin
41.4%
Op. Margin
6.0%
Net Margin
-3.8%
FCF Margin
2.6%
P/S Ratio (TTM)
2.2x
P/E Ratio (TTM)
—
YoY Rev Growth
+4.3%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$3M
$301K
-$2M
Q2 23
$4M
$1M
-$1M
Q3 23
$5M
$1M
-$1M
Q4 23
$5M
$1M
-$1M
Q1 24
$7M
$2M
-$300K
Q2 24
$5M
$1M
-$1M
Q3 24
$6M
$2M
-$575K
Q4 24
$8M
$3M
$621K
Q1 25
$8M
$3M
$1M
Q2 25
$6M
$3M
$570K
Q3 25
$6M
$2M
$20K
Q4 25
$8M
$3M
-$58K
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
3.7x
—
Q2 23
3.8x
—
Q3 23
3.7x
—
Q4 23
3.4x
—
Q1 24
2.8x
—
Q2 24
2.6x
—
Q3 24
2.5x
—
Q4 24
2.2x
—
Q1 25
2.2x
—
Q2 25
2.1x
33.8x
Q3 25
2.1x
25.6x
Q4 25
2.2x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$1M
-$3M
Q1 23
-$3M
-$3M
Q2 23
-$681K
-$1M
Q3 23
-$508K
-$928K
Q4 23
-$723K
-$804K
Q1 24
$419K
$348K
Q2 24
$582K
$471K
Q3 24
-$639K
-$728K
Q4 24
-$3K
-$199K
Q1 25
$2M
$1M
Q2 25
$2M
$1M
Q3 25
-$1M
-$2M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$1M
Q1 23
$682K
Q2 23
$708K
Q3 23
$421K
Q4 23
$81K
Q1 24
$70K
Q2 24
$111K
Q3 24
$88K
Q4 24
$196K
Q1 25
$329K
Q2 25
$155K
Q3 25
$594K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-42.6%
+5.0%
Q2 23
-8.5%
+8.0%
Q3 23
+12.5%
+21.6%
Q4 23
+30.3%
+10.0%
Q1 24
+110.6%
+32.5%
Q2 24
+54.9%
+41.8%
Q3 24
+11.4%
+0.1%
Q4 24
+52.1%
+16.9%
Q1 25
+11.2%
-8.0%
Q2 25
+17.8%
-14.3%
Q3 25
-8.4%
-16.7%
Q4 25
-1.6%
+7.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$65K
1.7%
Q1 23
$96K
2.8%
Q2 23
$76K
2.1%
Q3 23
$96K
1.8%
Q4 23
$101K
2.0%
Q1 24
$81K
1.1%
Q2 24
$98K
1.8%
Q3 24
$78K
1.3%
Q4 24
$69K
0.9%
Q1 25
$52K
0.6%
Q2 25
$67K
1.0%
Q3 25
$73K
1.3%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
$1M
$567K
$879K
—
Q2 23
$1M
$529K
$720K
—
Q3 23
$1M
$515K
$817K
—
Q4 23
$1M
$523K
$672K
—
Q1 24
$1M
$532K
$801K
—
Q2 24
$1M
$602K
$985K
—
Q3 24
$786K
$528K
$844K
—
Q4 24
$819K
$555K
$836K
—
Q1 25
$757K
$623K
$857K
—
Q2 25
$832K
$720K
$696K
—
Q3 25
$694K
$729K
$919K
—
Q4 25
$759K
—
—
$2M
marketcaparena.com
Revenue Segments
Quarter
marketcaparena.com
Revenue by Geography
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$3M
$0
$3M
Q2 23
$1M
$0
$1M
Q3 23
$2M
$0
$2M
Q4 23
$979K
$0
$979K
Q1 24
$960K
$0
$960K
Q2 24
$1M
$0
$1M
Q3 24
$4M
$0
$4M
Q4 24
$4M
$0
$4M
Q1 25
$5M
$0
$5M
Q2 25
$6M
$0
$6M
Q3 25
$4M
$0
$4M
Q4 25
$4M
$0
$4M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
8M
-0.0%
Q2 23
8M
+0.0%
Q3 23
8M
+0.0%
Q4 23
8M
+0.0%
Q1 24
8M
+0.0%
Q2 24
8M
+0.8%
Q3 24
8M
+4.5%
Q4 24
9M
+9.4%
Q1 25
9M
+0.5%
Q2 25
9M
+0.6%
Q3 25
9M
+0.2%
Q4 25
9M
+0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$223K
34
FY 15
$222K
46
FY 16
$212K
45
FY 17
$222K
47
FY 18
$215K
51
FY 19
$254K
54
FY 20
$252K
61
FY 21
$241K
80
FY 22
$251K
74
FY 23
$221K
79
FY 24
$353K
75
FY 25
$369K
75
marketcaparena.com